UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
If you want tighter expense control and explicit assignment of funds, zero based budgeting can be worth trying. This intro explains potential gains and a simple starting point.
26,943 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A major industrial player signals confidence with a $4.3 million stake move. This analysis explains what worthington ...
The semiconductor market could double by 2030 as AI, data centers, and EVs push demand higher. This guide breaks down...
In June 2026, one stock shines as a truly rated pick. This article explains why it earns the title and how everyday i...
A new wave of enterprise chip investments is shaking up the AI hardware landscape. This huge news broadcom stock deve...
After a slow stretch for home sales, many buyers and investors wonder if 2026 will flip the script. This guide breaks...
Starlink could change how we buy internet and phone services, and SpaceX's IPO adds a new layer of opportunity and ri...
Gas prices could push toward $4 a gallon again as a new IRS rule expands the gas expense deduction. The change target...
In March, oil price declines helped airline stocks rally even as the broader market parsed mixed signals. This articl...
AGNT, Inc. has completed its corporate transformation, changing its name and moving its domicile to Texas. The move i...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
A bond market roar is sending a clear message to stock market investors urgent: yields are rising, and that can press...